• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Intuitive Introduces Real-Time Surgical Insights for da Vinci 5

    9/12/25 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care
    Get the next $ISRG alert in real time by email

    SUNNYVALE, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the first in a series of new software capabilities for da Vinci 5, designed to enhance surgeon and hospital efficiency through the delivery of a range of real-time surgical insights.

    Da Vinci 5 has more than 10,000 times the computing power of da Vinci Xi. This enables innovative new system capabilities including:

    • Force Gauge — a speedometer-like visual indicator that shows the force being applied at the Force Feedback instrument tip.
    • In-Console Video Replay — an intraoperative feature that enables surgeons to revisit and review key moments from an ongoing procedure — without ever removing their head from the console.
    • Network CCM — a new feature that enables hospital teams to process software updates — including Force Gauge and In-Console Video Replay — remotely.

    "The expanded computing power of da Vinci 5 offers an opportunity to continuously optimize and extend platform performance capabilities through sequential software releases," said Intuitive Chief Executive Officer Dave Rosa. "We pay careful attention to our customers' long-term needs, and the integration of these latest features is the next step towards realizing what we set out to achieve with da Vinci 5 – helping surgeons and care teams to optimize efficiencies, deliver improved patient outcomes, and ultimately lower the total cost of care."

    Force Gauge shows the force applied at the Force Feedback instrument tip.

    Force Gauge

    When using Force Feedback instruments, da Vinci 5 now displays relative real-time force applied to tissue during surgery through Force Gauge—a speedometer-like visual indicator that shows the force being applied at the Force Feedback instrument tip. Force Gauge is designed to support a greater awareness of force applied to tissue, measuring force within a 0–6.5 Newton range.

    "We've had the opportunity to use da Vinci 5 Force Feedback technology for over a year and a half at Adventist Health Simi Valley, and we are finding that we are consistently applying less force to tissue during procedures," said Dr. Andrea Pakula, Medical Director of Robotic Surgery at Adventist Health.

    "Now, with the addition of the new Force Gauge feature, we have a real-time visual indicator of the force being applied through the instruments. This provides immediate feedback and adds another layer of information to allow us to further refine our technique. I'm excited to see how these enhancements could support gentler, safer surgery, as we remain focused on achieving the best possible outcomes for our patients."

    Recently published data in The American Journal of Surgery suggests that Force Feedback technology can reduce the total amount of force applied during surgery—without negatively impacting primary outcomes such as bowel function or length of hospital stay.1

    In-Console Video Replay

    In-Console Video Replay is an intraoperative feature that enables surgeons to revisit and review video from earlier moments in the same procedure—without ever removing their head from the console. The replay appears directly in their field of view, alongside a live picture-in-picture window for continuous situational awareness.

    Fully integrated into the da Vinci 5 system, In-Console Video Replay captures the entire procedure locally and temporarily, to support a surgeon's real-time decision-making, collaborative review between dual consoles, and improved procedural safety and efficiency.

    Network CCM

    Force Gauge and In-Console Video Replay will be made available to customers in the U.S. through Network CCM, a real-time system update feature for da Vinci 5. With Network CCM, new software features can be enabled remotely, which could help to reduce administrative burdens by enabling hospital teams to process new software updates remotely.

    The announcement of these new software capabilities for da Vinci 5 was made at Intuitive 360, an annual peer-to-peer educational forum where experiences, ideas and best practices are shared – all with the vision to provide better outcomes and equitable access to care.

    Force Gauge, In-Console Video Replay and Network CCM da Vinci 5 software features have all received 510(k) clearance from the U.S. Food & Drug Administration (FDA). These updates reflect the ongoing software innovation to enhance the da Vinci 5 platform, informed by early customer feedback and supported by our long-term development strategy.

    These features may not be available in all countries. Product availability is subject to regulatory approval in the specific market. Please contact your local Intuitive representative for product availability in your region.

    About Intuitive



    Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

    About da Vinci Surgical Systems



    There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

    For more information, please visit the company's website at www.intuitive.com.

    Important Safety Information



    For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, visit https://manuals.intuitivesurgical.com/market. For summary of the risks associated with surgery refer to www.intuitive.com/safety.

    Forward-Looking Statements



    This press release contains forward-looking statements which relate to expectations concerning matters that are not historical facts. Statements using words such as "estimates," "projects," "believes," "anticipates," "plans," "expects," "intends," "may," "will," "can," "could," "should," "would," "targeted," "potential," and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements are necessarily estimates reflecting the judgment of Intuitive's management and involve a number of risks and uncertainties that could cause actual results or impacts on its operations, financial performance, and business position to differ materially from those suggested by the forward-looking statements.

    These forward-looking statements include, but are not limited to, statements related to research and development of products and services, manufacturing of products, integration of products, obtaining of regulatory approvals, technical and other performance of products and services, and making products and services available to more patients and health care professionals.

    These forward-looking statements should be considered in light of various important factors and involve known and unknown risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of Intuitive, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, among others, economic conditions in the geographic markets in which we operate, changes in governmental regulations, regulatory approval priorities, resources, and timelines, regulatory enforcement priorities, governmental investigations and civil litigation, and other factors discussed in Intuitive's Annual Reports and other filings with relevant securities regulators.

    Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors identified under the heading "Risk Factors" in Intuitive's Annual Report on Form 10-K for the year ended December 31, 2024, as updated by its other filings with the U.S. Securities and Exchange Commission. Intuitive's actual results may differ materially and adversely from those expressed in any forward-looking statements, and it undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.

    Contact Information:

    Megan Elliott

    [email protected]

    +1 408-523-8181 ext. 6934681

    1 Chang GC, Upinder S, Debra, L, Vargas G, Shah S, Rashidi L. A pilot study on the impact of da Vinci 5's force feedback on clinical outcomes: Does it lead to less tissue trauma in colorectal surgery? The American Journal of Surgery (2025). https://doi.org/10.1016/j.amjsurg.2025.116518

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/92d49977-772b-4db1-900e-9387c91f322e



    Primary Logo

    Get the next $ISRG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ISRG

    DatePrice TargetRatingAnalyst
    1/27/2026$660.00Buy
    TD Cowen
    12/11/2025$635.00Buy → Neutral
    Citigroup
    7/23/2025Buy → Hold
    Erste Group
    6/9/2025$440.00Hold → Sell
    Deutsche Bank
    6/5/2025Hold → Buy
    Erste Group
    12/2/2024$522.00 → $650.00Equal-Weight → Overweight
    Morgan Stanley
    8/2/2024$380.00 → $510.00Neutral → Buy
    Redburn Atlantic
    7/10/2024$462.00 → $512.00Buy
    Citigroup
    More analyst ratings

    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & Chief Medical Officer Curet Myriam sold $260,316 worth of shares (526 units at $494.90), exercised 943 shares at a strike of $25.54 and covered exercise/tax liability with 417 shares (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    2/11/26 5:37:49 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    VP Corporate Controller Widman Fredrik converted options into 567 shares, covered exercise/tax liability with 302 shares and sold $65,830 worth of shares (133 units at $494.96), increasing direct ownership by 25% to 660 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    2/11/26 5:17:04 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Chief Executive Officer (CEO) Rosa David J. converted options into 1,436 shares and covered exercise/tax liability with 724 shares, increasing direct ownership by 0.31% to 229,570 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    2/10/26 4:28:39 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Da Vinci 5 Cleared for Cardiac Procedures

    SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization.         Cardiovascular disease remains the leading cause of death worldwide, claiming nearly 18 million lives each year.i More than two million patients worldwide undergo open heart surgery annuallyii, with most procedures requiring a sternotomy, an approach that involves splitting

    1/26/26 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    20 Million Patients Benefit from da Vinci Surgery Globally

    SUNNYVALE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that more than 20 million patients worldwide have been operated on by surgeons using da Vinci surgical systems. The milestone was reached as of the end of 2025, with more than 3.1 million da Vinci procedures performed last year alone. This achievement reflects the continued adoption of, and expanded patient access to, Intuitive's minimally invasive technology. "This achievement is a direct result of the dedication of surgeons and care teams around the globe to provide the best possible care for their pat

    1/23/26 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces Fourth Quarter Earnings

    SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with 493 in the fourth quarter of 2024. The fourth quarter 2025 da Vinci surgical system placements included 303 da Vinci 5 systems, compared with 174 i

    1/22/26 4:05:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Intuitive Surgical with a new price target

    TD Cowen initiated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $660.00

    1/27/26 8:46:58 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Surgical downgraded by Citigroup with a new price target

    Citigroup downgraded Intuitive Surgical from Buy to Neutral and set a new price target of $635.00

    12/11/25 8:53:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Surgical downgraded by Erste Group

    Erste Group downgraded Intuitive Surgical from Buy to Hold

    7/23/25 8:54:24 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    SEC Filings

    View All

    SEC Form 10-K filed by Intuitive Surgical Inc.

    10-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

    2/3/26 4:59:59 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

    1/22/26 4:05:12 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

    1/14/26 8:58:49 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Dr. Craig H. Barratt to Board of Directors

    Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute

    11/10/25 6:21:00 PM ET
    $ALAB
    $INTC
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    30 years of Innovation and Impact: Dan Larson's Inspiring Story

    SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

    5/27/25 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces CEO Transition Effective July 1, 2025

    President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

    5/15/25 9:05:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Financials

    Live finance-specific insights

    View All

    Intuitive Announces Fourth Quarter Earnings

    SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with 493 in the fourth quarter of 2024. The fourth quarter 2025 da Vinci surgical system placements included 303 da Vinci 5 systems, compared with 174 i

    1/22/26 4:05:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results

    SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational Highlights Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%. Average da Vinci system utilization increased 4%

    1/14/26 9:05:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces Third Quarter Earnings

    SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2025. Q3 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 20% compared with the third quarter of 2024. Da Vinci procedures grew approximately 19% and Ion procedures grew approximately 52%.The Company placed 427 da Vinci surgical systems, compared with 379 in the third quarter of 2024. The third quarter 2025 da Vinci surgical system placements included 240 da Vinci 5 systems, compared with 110 in the

    10/21/25 4:05:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/24 10:02:59 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/23 12:37:59 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/9/23 11:22:22 AM ET
    $ISRG
    Industrial Specialties
    Health Care